UNITED STATES: Pharma marketing may spur regulation
You must be signed in to read this analysis
In this article
- Consumer advertising
- Pending legislation
- Senate bill
- Tougher House proposals
- Waxman's role
- Committee agenda
- Advertising efficacy
- Ongoing debate
- Critical assessment
- Costs
- Unnecessary drugs?
- Industry position
- Doctors' roles
- Dialogue promotion?
- Increased awareness
- Self-regulation
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.